TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
JAMCO Pharma Consulting AB
Closing information (x1000 EUR)
| Closing information | 2023/09 | 2022/09 | 2021/09 |
| Turnover |
575
|
559
|
476 |
| Financial expenses |
0
|
32
|
0 |
| Earnings before taxes |
399
|
346
|
328 |
| EBITDA |
364
|
181
|
320 |
| Total assets |
1,935
|
1,668
|
1,335 |
| Current assets |
754
|
727
|
454 |
| Current liabilities |
249
|
176
|
76 |
| Equity capital |
1,657
|
1,407
|
1,179 |
| - share capital |
4
|
5
|
5 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Solvency |
85.6%
|
84.4%
|
88.3% |
| Turnover per employee |
288
|
280
|
238 |
| Profit as a percentage of turnover |
69.4%
|
61.9%
|
68.9% |
| Return on assets (ROA) |
20.6%
|
22.7%
|
24.6% |
| Current ratio |
302.8%
|
413.1%
|
597.4% |
| Return on equity (ROE) |
24.1%
|
24.6%
|
27.8% |
| Change turnover |
44
|
115
|
24 |
| Change turnover % |
8%
|
26%
|
5% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.